Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.62 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | CASP7 | P55210 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | PLAU | P00749 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16355165 | 0.97 | HSD17B10 (0.67) | HSD17B10TDP1GPR35ALDH1A1KMT2A | |
| SCHEMBL22566 | 0.97 | HSD17B10 (0.67) | HSD17B10TDP1GPR35ALDH1A1KMT2A | |
| SCHEMBL29577518 | 0.97 | HSD17B10 (0.67) | HSD17B10TDP1GPR35ALDH1A1KMT2A | |
| Hydrogen Sulfide SCHEMBL28883138 | 0.94 | HSD17B10 (0.64) | HSD17B10TDP1GPR35ALDH1A1KMT2A | |
| SCHEMBL6553154 | 0.94 | HSD17B10 (0.64) | HSD17B10TDP1GPR35ALDH1A1KMT2A | |
| SCHEMBL6553157 | 0.94 | HSD17B10 (0.64) | HSD17B10TDP1GPR35ALDH1A1KMT2A | |
| SCHEMBL27813528 | 0.94 | HSD17B10 (0.64) | HSD17B10TDP1GPR35ALDH1A1KMT2A | |
| Fluoride SCHEMBL11797732 | 0.94 | HSD17B10 (0.64) | HSD17B10TDP1GPR35ALDH1A1KMT2A | |
| Ammonia Solution, Strong SCHEMBL11649737 | 0.94 | HSD17B10 (0.64) | HSD17B10TDP1GPR35ALDH1A1KMT2A | |
| Fluoride SCHEMBL27513971 | 0.94 | HSD17B10 (0.64) | HSD17B10TDP1GPR35ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103409177-A | Methanol fuel oil for ships and preparation method thereof | HU RONGHAN | 2013-11-27 | — | — | CN | claimed |
| CN-106928071-A | A kind of method that selective catalytic hydrogenation reduction prepares the nitrophenol of 2 amino 4 | 九江善水科技股份有限公司 | 2017-07-07 | — | — | CN | disclosed |
| CN-106928071-A | A kind of method that selective catalytic hydrogenation reduction prepares the nitrophenol of 2 amino 4 | 九江善水科技股份有限公司 | 2017-07-07 | — | — | CN | disclosed |
| CN-103409177-A | Methanol fuel oil for ships and preparation method thereof | HU RONGHAN | 2013-11-27 | — | — | CN | disclosed |
| CN-102459093-A | Subcritical partial oxidation for treating nitration waste | NORAM INT LTD | 2012-05-16 | — | — | CN | disclosed |
| CN-102174272-A | Preparation method and product of sulphur black dye | ZHEJIANG CHANGZHENG CHEMICAL CO LTD | 2011-09-07 | — | — | CN | disclosed |
| EP-0954336-B1 | MEMBRANE INCORPORATION OF TEXAPHYRINS | PHARMACYCLICS INC (US) | 2004-02-25 | — | — | EP | disclosed |
| US-6375930-B2 | PARAMAGNETISM, PHOTOSENSITIVITY; IMAGING, DIAGNOSIS, DRUG DELIVERY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2002-04-23 | — | — | US | disclosed |
| US-20020006378-A1 | MEMBRANE INCORPORATION OF TEXAPHYRINS | PHARMACYCLICS, INC. | 2002-01-17 | — | — | US | disclosed |
| EP-0954336-A2 | MEMBRANE INCORPORATION OF TEXAPHYRINS | PHARMACYCLICS, INC. (US) | 1999-11-10 | — | — | EP | disclosed |
| CN-1225591-A | Membrane binding of texaphyrins | PHARMACYCLICS INC (US) | 1999-08-11 | — | — | CN | disclosed |
| WO-1997046262-A2 | MEMBRANE INCORPORATION OF TEXAPHYRINS | PHARMACYCLICS, INC. (US) | 1997-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020006378-A1 | MEMBRANE INCORPORATION OF TEXAPHYRINS | CD47, PHOSPHO1, TEX13A | HSD17B10 4348/4885TDP1 560/4885GPR35 3398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.